Evidence map›Paper›PMID 42125321›Full record

ArticleBeilstein journal of nanotechnology2026

Advances in nanotechnology applied to natural products.

Douglas Dourado, Fábio Rocha Formiga, Éverton do Nascimento Alencar, Franceline Reynaud

Abstract readEditorial
In one paragraph

Article in Beilstein journal of nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Douglas DouradoDepartment of Immunology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420, Recife, PE, Brazil.ORCID https://orcid.org/0000-0003-3445-5217
Fábio Rocha FormigaDepartment of Immunology, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), 50670-420, Recife, PE, Brazil.ORCID https://orcid.org/0000-0003-1553-0533
Éverton do Nascimento AlencarLaboratory of Micro and Nanostructured Systems (LASMINano), Federal University of Mato Grosso do Sul (UFMS), 79070-900, Campo Grande, MS, Brazil.ORCID https://orcid.org/0000-0002-6148-6804
Franceline ReynaudUniversité de Lorraine, CITHEFOR EA3452 - Nancy, France.ORCID https://orcid.org/0000-0002-9053-0931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug deliverynanomaterialsnanomedicinenatural compoundssustainability

Identifiers

PMID42125321
PMCPMC13159234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.